Interesting, and particularly surprising candidates are RTN4 and TP53INP2 that interact with BACE1, and were predicted using our approach but their relevance to mechanism of AD has been barely studied in the literature, although their interactions are targeted in clinical trials for testing potential AD drugs. This evidence concerns the gene TP53INP2 and Alzheimer disease.